The effect of methylguanidine on norepinephrine metabolism in isolated, perfused spleen and heart.
D000818:Animals; D002415:Cats; D003042:Cocaine / Q000494:pharmacology; D003641:Deamination; D004558:Electric Stimulation; D005260:Female; D006146:Guanidines / Q000494:pharmacology*; D006321:Heart / Q000187:drug effects; D066298:In Vitro Techniques; D008297:Male; D008995:Monoamine Oxidase / Q000378:metabolism; D008996:Monoamine Oxidase Inhibitors / Q000494:pharmacology; D009206:Myocardium / Q000378:metabolism*; D009638:Norepinephrine / Q000378:metabolism*; D010477:Perfusion; D051381:Rats; D012110:Reserpine / Q000494:pharmacology; D012701:Serotonin / Q000378:metabolism; D013154:Spleen / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D013997:Time Factors; D014316:Tritium
D006146:Guanidines; D008996:Monoamine Oxidase Inhibitors; D014316:Tritium; D012701:Serotonin; D012110:Reserpine; D008995:Monoamine Oxidase; D003042:Cocaine; D009638:Norepinephrine